| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.21 | 5e-06 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.066 | 0.2 |